SCHEMBL13620950

SCHEMBL13620950

CC(C)[C@@H]1CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7600258 1.00
SCHEMBL16707759 0.85 NCF1 (0.34)
SCHEMBL1615410 0.83
SCHEMBL2756894 0.83
SCHEMBL6891743 0.83
SCHEMBL13416621 0.81 CHRNB4 (0.43)
SCHEMBL7600904 0.81 CHRNB4 (0.43)
SCHEMBL17735692 0.81 CHRNB4 (0.43)
SCHEMBL19334296 0.81
SCHEMBL25020549 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230364070-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ANTARES THERAPEUTICS, INC. 2023-11-16 US disclosed
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 WO disclosed
US-20180186782-A1 AMIDE COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2018-07-05 US disclosed
WO-2009143507-A2 SILENT DESENSITIZERS OF NEURONAL NACHR AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2009-11-26 WO disclosed